Human plasma metabolomics in age-related macular degeneration (AMD) using nuclear magnetic resonance spectroscopy.

Human plasma metabolomics in age-related macular degeneration (AMD) using nuclear magnetic resonance spectroscopy.

To differentiate the plasma metabolomic profile of patients with age related macular degeneration (AMD) from that of controls, by Nuclear Magnetic Resonance (NMR) spectroscopy.Two cohorts (total of 396 subjects) representative of central Portugal and Boston, USA phenotypes were studied. For each coh...

Full description

Bibliographic Details
Main Authors:	Inês Laíns, Daniela Duarte, António S Barros, Ana Sofia Martins, João Gil, John B Miller, Marco Marques, Tânia Mesquita, Ivana K Kim, Maria da Luz Cachulo, Demetrios Vavvas, Isabel M Carreira, Joaquim N Murta, Rufino Silva, Joan W Miller, Deeba Husain, Ana M Gil
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5436712?pdf=render

Similar Items

Age-Related Macular Degeneration (AMD): A View to the Future
by: Joan W. Miller, et al.
Published: (2021-03-01)

Human Plasma Metabolomics in Age-Related Macular Degeneration: Meta-Analysis of Two Cohorts
by: Inês Laíns, et al.
Published: (2019-07-01)

Urinary Mass Spectrometry Profiles in Age-Related Macular Degeneration
by: Ines Lains, et al.
Published: (2022-02-01)

Plasma Metabolomic Profiles Associated with Three-Year Progression of Age-Related Macular Degeneration
by: Ines Lains, et al.
Published: (2022-01-01)

Association of Human Plasma Metabolomics with Delayed Dark Adaptation in Age-Related Macular Degeneration
by: Kevin M. Mendez, et al.
Published: (2021-03-01)

Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Meta-Analysis
by: Jonathan B. Lin, et al.
Published: (2022-04-01)

Neuroprotection for Age-Related Macular Degeneration
by: Jonathan B. Lin, MD, PhD, et al.
Published: (2022-12-01)

Systemic Dyslipidemia in Age-related Macular Degeneration
by: Brandon Li, et al.
Published: (2024-01-01)

A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration
by: Omar A. Halawa, et al.
Published: (2021-06-01)

Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
by: Luis García-Onrubia, et al.
Published: (2020-08-01)

Targeted therapy in age-related macular degeneration (AMD)
by: Klaudia Daria Szumna, et al.
Published: (2020-03-01)

Plasma Metabolites Associated with OCT Features of Age-Related Macular Degeneration
by: Ines Lains, MD, PhD, et al.
Published: (2024-01-01)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
by: Sonali Nashine
Published: (2021-09-01)

Treatment of age related macular degeneration (AMD) currently and in the past
by: Klaudia Brożyna, et al.
Published: (2018-08-01)

Genetic risk factors and age-related macular degeneration (AMD)
by: Maryam Mousavi, et al.
Published: (2013-10-01)

Treatment of age related macular degeneration (AMD) currently and in the past
by: Klaudia Brożyna, et al.
Published: (2018-08-01)

Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration
by: Jonathan B. Lin, MD, PhD, et al.
Published: (2022-06-01)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
by: Mayank Choubey, et al.
Published: (2023-11-01)

Characterizing Macular Neovascularization in Myopic Macular Degeneration and Age-Related Macular Degeneration Using Swept Source OCTA
by: Sayah DN, et al.
Published: (2023-12-01)

New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
by: Prem Patel, et al.
Published: (2021-05-01)

Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
by: Otsuji T, et al.
Published: (2013-07-01)

Subthreshold Exudative Choroidal Neovascularization (CNV): Presentation of This Uncommon Subtype and Other CNVs in Age-Related Macular Degeneration (AMD)
by: Vivian Paraskevi Douglas, et al.
Published: (2022-04-01)

Novel Epigenetic Clock Biomarkers of Age-Related Macular Degeneration
by: Saurav Mallik, et al.
Published: (2022-06-01)

Prevalence of Geographic Atrophy in Advanced Age-Related Macular Degeneration (AMD) in Daily Practice
by: Alaa Din Abdin, et al.
Published: (2023-07-01)

Current barriers to treatment for wet age-related macular degeneration (wAMD): findings from the wAMD patient and caregiver survey
by: Varano M, et al.
Published: (2015-12-01)

Measuring the Contrast Sensitivity Function in Non-Neovascular and Neovascular Age-Related Macular Degeneration: The Quantitative Contrast Sensitivity Function Test
by: Filippos Vingopoulos, et al.
Published: (2021-06-01)

Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD)
by: Aira Sarkar, et al.
Published: (2021-09-01)

Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
by: Tan CS, et al.
Published: (2022-03-01)

Potential Role of Myeloid-Derived Suppressor Cells (MDSCs) in Age-Related Macular Degeneration (AMD)
by: Anu Kauppinen, et al.
Published: (2020-03-01)

Inner blood-retina barrier involvement in dry age-related macular degeneration (AMD) pathology
by: Natalie Hudson, et al.
Published: (2020-01-01)

Metabolomics and Age-Related Macular Degeneration
by: Connor N. Brown, et al.
Published: (2018-12-01)

Antioxidative Role of Heterophagy, Autophagy, and Mitophagy in the Retina and Their Association with the Age-Related Macular Degeneration (AMD) Etiopathogenesis
by: Małgorzata Nita, et al.
Published: (2023-06-01)

Lifestyle Intervention Randomized Controlled Trial for Age-Related Macular Degeneration (AMD-Life): Study Design
by: Alexandra P. M. de Koning-Backus, et al.
Published: (2023-01-01)

Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD)
by: Mark Fields, et al.
Published: (2016-12-01)

Analysis of genetic polymorphisms for age-related macular degeneration (AMD) in Chinese Tujia ethnic minority group
by: Shengchun Liu, et al.
Published: (2019-01-01)

Bevacizumab cured age-related macular degeneration (AMD) via down-regulate TLR2 pathway
by: Wang Zhi, et al.
Published: (2014-05-01)

A qualitative exploration of Australian eyecare professional perspectives on Age-Related Macular Degeneration (AMD) care.
by: Isabelle Jalbert, et al.
Published: (2020-01-01)

Correlation between Macular Neovascularization (MNV) Type and Druse Type in Neovascular Age-Related Macular Degeneration (AMD) Based on the CONAN Classification
by: Daniel Rudolf Muth, et al.
Published: (2022-09-01)

Revolutionizing Patient Monitoring in Age-Related Macular Degeneration: A Comparative Study on the Necessity and Efficiency of the AMD VIEWER
by: Hitoshi Tabuchi, et al.
Published: (2023-12-01)

HtrA1 serine protease expression levels on age-related macular degeneration (AMD) patients in Yogyakarta
by: Supanji Supanji, et al.
Published: (2020-01-01)